Reinier Schlingemann

Research output

Research output per year 1985 1996 2002 2003 2004 2006 2007 2010 2012 2013 2014 2015 2016 2017 2018 2019 2022 2023 2024

• 193 Article
• 18 Review article
• 11 Comment/Letter to the editor
• 4 Chapter
• 3 More
  • 1 Book
  • 1 Conference contribution
  • 1 Letter

Research output per year

Research output per year

Search results

• Hemizygous deletion of CTGF/CCN2 does not suffice to prevent fibrosis of the severely injured kidney

  Falke, L. L., Dendooven, A., Leeuwis, J. W., Nguyen, T. Q., van Geest, R. J., van der Giezen, D. M., Broekhuizen, R., Lyons, K., Stoop, R., Kemperman, H., Schlingemann, R., Joles, J. A. & Goldschmeding, R., 2012, In: Matrix Biology. 31, 7-8, p. 421-431

  Research output: Contribution to journal › Article › Academic › peer-review
  26 Citations (Scopus)

• High recurrence rate in patients with choroidal hemangioma treated with limited single spot photodynamic therapy during long-term follow-up

  Stehouwer, M., Schlingemann, R. O. & Verbraak, F. D., 1 Nov 2020, In: Acta ophthalmologica. 98, 7, p. 679-686 8 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  6 Citations (Scopus)

• High-salt intake affects retinal vascular tortuosity in healthy males: an exploratory randomized cross-over trial

  Wenstedt, E. F. E., Beugelink, L., Schrooten, E. M., Rademaker, E., Rorije, N. M. G., Wouda, R. D., Schlingemann, R. O., Wong, T. Y. & Vogt, L., 1 Dec 2021, In: Scientific reports. 11, 1, 801.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  3 Citations (Scopus)

• HIV-Associated Neuroretinal Disorder in Patients With Well-Suppressed HIV-Infection: A Comparative Cohort Study

  AUTHOR GROUP, Mar 2016, In: Investigative Ophthalmology & Visual Science. 57, 3, p. 1388-1397

  Research output: Contribution to journal › Article › Academic › peer-review
  18 Citations (Scopus)

• Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fibrovascular membranes

  Klaassen, I., De Vries, E. W., Vogels, I. M. C., Van Kampen, A. H. C., Bosscha, M. I., Steel, D. H. W., Van Noorden, C. J. F., Lesnik-Oberstein, S. Y. & Schlingemann, R. O., 1 Nov 2017, In: PLOS ONE. 12, 11, p. e0187304 e0187304.

  Research output: Contribution to journal › Article › Academic › peer-review
  51 Citations (Scopus)

• Idiopathic granulomatous orbital inflammation

  Mombaerts, I., Schlingemann, R. O., Goldschmeding, R. & Koornneef, L., 1996, In: Ophthalmology. 103, 12, p. 2135-2141

  Research output: Contribution to journal › Article › Academic › peer-review
  67 Citations (Scopus)

• IGF2 and IGF1R identified as novel tip cell genes in primary microvascular endothelial cell monolayers

  Dallinga, M. G., Yetkin-Arik, B., Kayser, R. P., Vogels, I. M. C., Nowak-Sliwinska, P., Griffioen, A. W., van Noorden, C. J. F., Klaassen, I. & Schlingemann, R. O., 2018, In: Angiogenesis. 21, 4, p. 823-836

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  25 Citations (Scopus)

• IGF-binding proteins 3 and 4 are regulators of sprouting angiogenesis

  Dallinga, M. G., Habani, Y. I., Kayser, R. P., van Noorden, C. J. F., Klaassen, I. & Schlingemann, R. O., 1 Apr 2020, In: Molecular Biology Reports. 47, 4, p. 2561-2572 12 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  12 Citations (Scopus)

• Immunohistochemical localization of vascular endothelial growth factor receptors-1, -2 and -3 in human spinal cord: altered expression in amyotrophic lateral sclerosis

  Spliet, W. G. M., Aronica, E., Ramkema, M., Witmer, A. N., Schlingemann, R. O., de Jong, J. M. B. V. & Troost, D., 2004, In: Neuropathology and applied neurobiology. 30, 4, p. 351-359

  Research output: Contribution to journal › Article › Academic › peer-review
  15 Citations (Scopus)

• Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry

  Fight Retinal Blindness! Study Group, Nov 2022, In: Ophthalmology Retina. 6, 11, p. 1044-1053 10 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  3 Citations (Scopus)

• Increased expression of endothelial antigen PAL-E in human diabetic retinopathy correlates with microvascular leakage

  Schlingemann, R. O., Hofman, P., Vrensen, G. F. & Blaauwgeers, H. G., 1999, In: Diabetologia. 42, 5, p. 596-602

  Research output: Contribution to journal › Article › Academic › peer-review
  52 Citations (Scopus)

• INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY

  Feenstra, H. M. A., Diederen, R. M. H., Lamme, M. J. C. M., Tsonaka, R., Fauser, S., Yzer, S., van Rijssen, T., Gkika, T., Downes, S. M., Schlingemann, R. O., Hoyng, C. B., van Dijk, E. H. C. & Boon, C. J. F., 1 Mar 2023, In: Retina (Philadelphia, Pa.). 43, 3, p. 379-388 10 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  5 Citations (Scopus)

• In vivo angiogenic phenotype of endothelial cells and pericytes induced by vascular endothelial growth factor-A

  Witmer, A. N., van Blijswijk, B. C., van Noorden, C. J. F., Vrensen, G. F. J. M. & Schlingemann, R. O., 2004, In: Journal of Histochemistry and Cytochemistry. 52, 1, p. 39-52

  Research output: Contribution to journal › Article › Academic › peer-review
  85 Citations (Scopus)

• Involvement of the ubiquitin-proteasome system in the expression of extracellular matrix genes in retinal pigment epithelial cells

  Ramos de Carvalho, J. E., Verwoert, M. T., Vogels, I. M. C., Reits, E. A., van Noorden, C. J. F., Klaassen, I. & Schlingemann, R. O., 2018, In: Biochemistry and biophysics reports. 13, p. 83-92

  Research output: Contribution to journal › Article › Academic › peer-review
  13 Citations (Scopus)

• Is automated screening for diabetic retinopathy indeed not yet ready as stated by Grauslund et al.?

  Verbraak, F. D., Schmidt-Erfurth, U., Grzybowski, A., Abramoff, M. & Schlingemann, R., 1 Jan 2019, In: Acta ophthalmologica. 98, 2, p. e257-e258

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
  1 Citation (Scopus)

• Is leukostasis a crucial step or epiphenomenon in the pathogenesis of diabetic retinopathy?

  van der Wijk, A-E., Hughes, J. M., Klaassen, I., van Noorden, C. J. F. & Schlingemann, R. O., 2017, In: Journal of leukocyte biology. 102, 4, p. 993-1001

  Research output: Contribution to journal › Review article › Academic › peer-review
  28 Citations (Scopus)

• Ki-67 detects a nuclear matrix-associated proliferation-related antigen. I. Intracellular localization during interphase

  Verheijen, R., Kuijpers, H. J., Schlingemann, R. O., Boehmer, A. L., van Driel, R., Brakenhoff, G. J. & Ramaekers, F. C., 1989, In: Journal of Cell Science. 92 ( Pt 1), p. 123-130

  Research output: Contribution to journal › Article › Academic › peer-review

  214 Citations (Scopus)

• Lack of blood-brain barrier properties in microvessels of the prelaminar optic nerve head

  Hofman, P., Hoyng, P., VanderWerf, F., Vrensen, G. F. & Schlingemann, R. O., 2001, In: Investigative Ophthalmology & Visual Science. 42, 5, p. 895-901

  Research output: Contribution to journal › Article › Academic › peer-review

  94 Citations (Scopus)

• Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma

  Schlingemann, R. O., Rietveld, F. J., de Waal, R. M., Bradley, N. J., Skene, A. I., Davies, A. J., Greaves, M. F., Denekamp, J. & Ruiter, D. J., 1990, In: Laboratory investigation; a journal of technical methods and pathology. 62, 6, p. 690-696

  Research output: Contribution to journal › Article › Academic › peer-review

  196 Citations (Scopus)

• Longstanding symptomatic choroidal hemangioma managed with limited PDT as initial or salvage therapy

  Verbraak, F. D., Schlingemann, R. O., Keunen, J. E. E. & de Smet, M. D., 2003, In: Graefe s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 241, 11, p. 891-898

  Research output: Contribution to journal › Article › Academic › peer-review
  46 Citations (Scopus)

• Long Survival and Preservation of Good Visual Acuity in a Patient with Bilateral Diffuse Uveal Melanocytic Proliferation

  van Noort, B. C., Keunen, J. E. E., Schlingemann, R. O. & Marinkovic, M., Jan 2019, In: Ocular Oncology and Pathology. 5, 1, p. 75-78 4 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  11 Citations (Scopus)

• Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3

  Feenstra, H. M. A., van Dijk, E. H. C., van Rijssen, T. J., Tsonaka, R., Diederen, R. M. H., Hoyng, C. B., Schlingemann, R. O. & Boon, C. J. F., Mar 2023, In: Graefe's archive for clinical and experimental ophthalmology. 261, 3, p. 659-668 10 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  4 Citations (Scopus)

• Mechanisms of ocular angiogenesis and its molecular mediators

  Siemerink, M. J., Augustin, A. J. & Schlingemann, R. O., 2010, In: Developments in ophthalmology. 46, p. 4-20

  Research output: Contribution to journal › Article › Academic › peer-review
  64 Citations (Scopus)

• Microcirculation and atherothrombotic parameters in prolactinoma patients: a pilot study

  Reuwer, A. Q., Sondermeijer, B. M., Battjes, S., van Zijderveld, R., Stuijver, D. J. F., Bisschop, P. H., Twickler, M. T. B., Meijers, J. C. M., Schlingemann, R. O. & Stroes, E. S., 2012, In: Pituitary. 15, 4, p. 472-481

  Research output: Contribution to journal › Article › Academic › peer-review
  13 Citations (Scopus)

• MicroRNA expression profile in the vitreous of proliferative diabetic retinopathy patients and differences from patienttreated with anti-VEGF therapy

  Friedrich, J., Steel, D. H. W., Schlingemann, R. O., Koss, M. J., Hammes, H-P., Krenning, G. & Klaassen, I., 1 May 2020, In: Translational Vision Science and Technology. 9, 6, p. 1-10 10 p., 16.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  17 Citations (Scopus)

• Microvascular changes in experimental vascular endothelial growth factor-induced retinopathy

  Hofman, P., Blaauwgeers, H. G. T., Tolentino, M. J., Vrensen, G. F. J. M. & Schlingemann, R. O., 1997, In: Endothelium: Journal of Endothelial Cell Research. 5, 4, p. 354-355 2 p.

  Research output: Contribution to journal › Article › Academic › peer-review

• Microvascular Complications in the Eye: Diabetic Retinopathy

  Bosma, E. K., van Noorden, C. J. F., Klaassen, I. & Schlingemann, R. O., 29 Oct 2018, Diabetic Nephropathy: Pathophysiology and Clinical Aspects. Springer International Publishing, p. 305-321 (Diabetic Nephropathy: Pathophysiology and Clinical Aspects).

  Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review
  9 Citations (Scopus)

• Mirna levels as a biomarker for anti-vegf response in patients with diabetic macular edema

  Vader, M. J. C., Habani, Y. I., Schlingemann, R. O., Klaassen, I. & Vader, M. J. C., 1 Dec 2021, In: Journal of Personalized Medicine. 11, 12, 1297.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  1 Citation (Scopus)

• Mobile ultra-clean unidirectional airflow screen reduces air contamination in a simulated setting for intra-vitreal injection

  Lapid-Gortzak, R., Traversari, R., van der Linden, J. W., Lesnik Oberstein, S. Y., Lapid, O. & Schlingemann, R. O., 2017, In: International ophthalmology. 37, 1, p. 131-137

  Research output: Contribution to journal › Article › Academic › peer-review
  12 Citations (Scopus)

• Modulation of the Proteasome Pathway by Nano-Curcumin and Curcumin in Retinal Pigment Epithelial Cells

  Ramos de Carvalho, J. E., Verwoert, M. T., Vogels, I. M. C., Schipper-Krom, S., van Noorden, C. J. F., Reits, E. A., Klaassen, I. & Schlingemann, R. O., 2018, In: Ophthalmic research. 59, 2, p. 98-109

  Research output: Contribution to journal › Article › Academic › peer-review
  5 Citations (Scopus)

• Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy

  Wisniewska-Kruk, J., Klaassen, I., Vogels, I. M. C., Magno, A. L., Lai, C-M., van Noorden, C. J. F., Schlingemann, R. O. & Rakoczy, E. P., 2014, In: Experimental eye research. 122, p. 123-131

  Research output: Contribution to journal › Article › Academic › peer-review
  62 Citations (Scopus)

• Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions

  Klaassen, I., van Noorden, C. J. F. & Schlingemann, R. O., 2013, In: Progress in Retinal and Eye Research. 34, p. 19-48

  Research output: Contribution to journal › Article › Academic › peer-review
  518 Citations (Scopus)

• Monoclonal antibody-defined human endothelial antigens as vascular markers

  Ruiter, D. J., Schlingemann, R. O., Rietveld, F. J. & de Waal, R. M., 1989, In: Journal of Investigative Dermatology. 93, 2 Suppl, p. 25S-32S

  Research output: Contribution to journal › Article › Academic › peer-review
  50 Citations (Scopus)

• Monoclonal antibody PAL-E specific for endothelium

  Schlingemann, R. O., Dingjan, G. M., Emeis, J. J., Blok, J., Warnaar, S. O. & Ruiter, D. J., 1985, In: Laboratory investigation; a journal of technical methods and pathology. 52, 1, p. 71-76

  Research output: Contribution to journal › Article › Academic › peer-review

  238 Citations (Scopus)

• Naar schatting 11 miljoen Amerikanen onnodig slechtziend

  Translated title of the contribution: An estimation of 11 million Americans with unnecessary visual impairmentGerbrandy, S. J. F. & Schlingemann, R. O., 20 Jan 2007, In: Nederlands Tijdschrift voor Geneeskunde. 151, 3, p. 217 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

• Natural history and rate of progression of retinopathy in adult patients with sickle cell disease: an 11-year follow-up study

  Brandsen, R. P., Diederen, R. M. H., Bakhlakh, S., Nur, E., Schlingemann, R. O. & Biemond, B. J., 11 Jul 2023, In: Blood. 7, 13, p. 3080-3086 7 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

• Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcome

  Chung, W. H., van Dijk, E. H. C., Mohabati, D., Dijkman, G., Yzer, S., de Jong, E. K., Fauser, S., Schlingemann, R. O., Hoyng, C. B. & Boon, C. J. F., 2017, In: Clinical ophthalmology (Auckland, N.Z.). 11, p. 63-70

  Research output: Contribution to journal › Article › Academic › peer-review
  4 Citations (Scopus)

• Netvliesloslating door fluorchinolonen

  Translated title of the contribution: Retinal detachment by fluoroquinolonesSchlingemann, R., Jul 2012, In: Nederlands Tijdschrift voor Geneeskunde. 156, 27, A5045.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

• Neuroretinal Degeneration in HIV Patients Without Opportunistic Ocular Infections in the cART Era

  Demirkaya, N., Wit, F., Schlingemann, R. & Verbraak, F., 2015, In: AIDS patient care and STDs. 29, 10, p. 519-532

  Research output: Contribution to journal › Article › Academic › peer-review
  17 Citations (Scopus)

• New approaches for the treatment of diabetic macular oedema: Recommendations by an expert panel

  Bandello, F., Cunha-Vaz, J., Chong, N. V., Lang, G. E., Massin, P., Mitchell, P., Porta, M., Prünte, C., Schlingemann, R. & Schmidt-Erfurth, U., 1 Jun 2013, In: Diabetes Technology and Therapeutics. 15, SUPPL.1, p. S129-S130

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access

• New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel

  Bandello, F., Cunha-Vaz, J., Chong, N. V., Lang, G. E., Massin, P., Mitchell, P., Porta, M., Prünte, C., Schlingemann, R. & Schmidt-Erfurth, U., 2012, In: Eye (London, England). 26, 4, p. 485-493

  Research output: Contribution to journal › Article › Academic › peer-review
  90 Citations (Scopus)

• NF-kappa B-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis

  Noort, A. R., van Zoest, K. P. M., Weijers, E. M., Koolwijk, P., Maracle, C. X., Novack, D. V., Siemerink, M. J., Schlingemann, R. O., Tak, P. P. & Tas, S. W., 2014, In: Journal of pathology. 234, 3, p. 375-385

  Research output: Contribution to journal › Article › Academic › peer-review
  77 Citations (Scopus)

• Nieuwe geneesmiddelen voor maculadegeneratie

  Walland, S. C. & Schlingemann, R. O., 2008, Geneesmiddelenbulletin. Anonymous, A. (ed.). S.l.: s.n., p. 31

  Research output: Chapter in Book/Report/Conference proceeding › Chapter › Professional

• Oogafwijkingen bij diabetes op oudere leeftijd: lang niet altijd retinopathie, maar vaak maculadegeneratie

  Schlingemann, R. O., 2009, In: DiabeteSpecialist. 2009, 8, p. 18-19

  Research output: Contribution to journal › Article › Professional

• Oogklachten wijzend op een tumor elders in het lichaam

  Marinkovic, M., van Lanschot, J. J. B., Schlingemann, R. O., de Smet, M. D. & Saeed, P., 2002, In: Nederlands Tijdschrift voor Geneeskunde. 146, 50, p. 2393-2396

  Research output: Contribution to journal › Article › Professional

  1 Citation (Scopus)

• Oogproblemen bij diabetes

  Schlingemann, R. O., 2009, In: Patient care. 2009, 36, p. 5-8

  Research output: Contribution to journal › Article › Academic › peer-review

• Oogproblemen door contactlenzen: een advies van de Gezondheidsraad

  Schlingemann, R. O. & Nieuwendaal, C. P., 2002, In: Nederlands Tijdschrift voor Geneeskunde. 146, 35, p. 1616-1619

  Research output: Contribution to journal › Article › Professional

  3 Citations (Scopus)

• Optical density filters modeling media opacities cause decreased SD-OCT retinal layer thickness measurements with inter- and intra-individual variation

  Darma, S., Kok, P. H. B., van den Berg, T. J. T. P., Abràmoff, M. D., Faber, D. J., Hulsman, C. A., Zantvoord, F., Mourits, M. P., Schlingemann, R. O. & Verbraak, F. D., 2015, In: Acta ophthalmologica. 93, 4, p. 355-361

  Research output: Contribution to journal › Article › Academic › peer-review
  19 Citations (Scopus)

• Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study

  Wakelkamp, I. M. M. J., Tan, H., Saeed, P., Schlingemann, R. O., Verbraak, F. D., Blank, L. E. C. M., Prummel, M. F. & Wiersinga, W. M., Aug 2004, In: Ophthalmology. 111, 8, p. 1557-1562 6 p.

  Research output: Contribution to journal › Article › Academic › peer-review
  116 Citations (Scopus)

• Orthogonal polarization spectral imaging of conjunctival microcirculation

  van Zijderveld, R., Ince, C. & Schlingemann, R. O., 2014, In: Graefe s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 252, 5, p. 773-779

  Research output: Contribution to journal › Article › Academic › peer-review
  25 Citations (Scopus)